Immune Checkpoint Inhibitors-induced Thyroid Dysfunction in Patients with Advanced Malignancies

Background: Immune checkpoint inhibitors (ICIs), including antiprogrammed cell death receptor-1, antiprogrammed cell death ligand-1, and anticytotoxic T-lymphocyte-antigen 4, have improved patients’ outcome in advanced malignancies. These agents are associated with immune-related adverse events, inc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Muhammad Latif, Elamin Abdelgadir, Mohamed Omara, Fauzia Rashid, Syed Tirmazy, Faraz Khan, Maroun El Khoury, Alaaeldin Bashier, Fatheya Alawadi, Kaltar Das, Susheel Kumar, Abdul Basit, Dalia El-Shourbagy, Dina Hamza, Faisal Azam
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Shiraz University of Medical Sciences 2022-10-01
Colecção:	Middle East Journal of Cancer
Assuntos:	immunotherapy hypothyroidism malignancy
Acesso em linha:	https://mejc.sums.ac.ir/article_48393_a064949aa8ea057da78e2d4db08ca2d6.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!